a-86929 a-86929 a-86929 is a synthetic compound that acts as a selective dopamine receptor d1 agonist. it was developed as a possible treatment for parkinson's disease, as well as for other applications such as treatment of cocaine addiction, but while it had reasonable efficacy in humans it also caused dyskinesias and has not been continued. it has mainly been used as its diacetate ester prodrug adrogolide (abt-431), which has better bioavailability. adrogolide a-86929 names preferred iupac name (5ar,11bs)-2-propyl-4,5,5a,6,7,11b-hexahydrobenzothienoquinoline-9,10-diol identifiers cas number 166591-11-3 y 3d model (jsmol) interactive image chembl chembl28338 y chemspider 8017113 y pubchem cid 9841398 unii 69mg3oza0h y comptox dashboard (epa) dtxsid50938440 inchi inchi=1s/c18h21no2s/c1-2-3-11-7-13-17(22-11)9-19-14-5-4-10-6-15(20)16(21)8-12(10)18(13)14/h6-8,14,18-21h,2-5,9h2,1h3/t14-,18+/m1/s1 ykey: rehaklryabhsqj-kdofpfpssa-n yinchi=1/c18h21no2s/c1-2-3-11-7-13-17(22-11)9-19-14-5-4-10-6-15(20)16(21)8-12(10)18(13)14/h6-8,14,18-21h,2-5,9h2,1h3/t14-,18+/m1/s1key: rehaklryabhsqj-kdofpfpsbo smiles oc1cc3c(cc1o)ccc4c3c2cc(ccc)sc2cn4 properties chemical formula c18h21no2s molar mass 315.429 g/mol except where otherwise noted, data are given for materials in their standard state (at 25 °c , 100 kpa). n verify (what is yn ?) infobox references